The role of glutamate and its receptors in mesocorticolimbic dopaminergic regions in opioid addiction

Neuroscience and Biobehavioral Reviews

Volumn 33, Issue 6, 2009, Pages 864-873

  Guo, Yuan ^a   Wang, Hui Ling ^a,b   Xiang, Xiao Hui ^c   Zhao, Yan ^a  

^a MEDICAL SCHOOL OF XI AN JIAOTONG UNIVERSITY   (China)

^b NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^c MEDICAL COLLEGE OF CHINESE PEOPLE'S ARMED POLICE FORCES   (China)

Author keywords

Glutamate; Glutamate receptor; Mesocorticolimbic dopaminergic regions; Opioid addiction

Indexed keywords

4 AMINOBUTYRIC ACID; CALCIUM ION; CYCLIC AMP; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; CYCLIC GMP; DOPAMINE; GLUTAMATE RECEPTOR; GLUTAMIC ACID; IONOTROPIC RECEPTOR; METABOTROPIC RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; N METHYL DEXTRO ASPARTIC ACID; NEUROPEPTIDE; NEUROTRANSMITTER; NITRIC OXIDE; OPIATE; PROTEIN KINASE C; SUBSTANCE P;

AMYGDALOID NUCLEUS; BRAIN DEPTH STIMULATION; CALCIUM TRANSPORT; DOPAMINERGIC ACTIVITY; DOPAMINERGIC SYSTEM; GENE TRANSLOCATION; HUMAN; MESOCORTICOLIMBIC DOPAMINERGIC REGION; MESOLIMBIC DOPAMINERGIC SYSTEM; METABOLIC ACTIVATION; NERVE CELL; NEUROTRANSMISSION; NONHUMAN; NUCLEUS ACCUMBENS; OPIATE ADDICTION; PRIORITY JOURNAL; PROTEIN INTERACTION; PSYCHOLOGICAL ASPECT; RECEPTOR UPREGULATION; REVIEW; SENSORY NERVE; SIGNAL TRANSDUCTION; SODIUM TRANSPORT; SYNAPTIC TRANSMISSION; VENTRAL TEGMENTUM;

ANIMALS; BRAIN; DOPAMINE; GAMMA-AMINOBUTYRIC ACID; GLUTAMIC ACID; HUMANS; NEURONS; OPIOID PEPTIDES; OPIOID-RELATED DISORDERS; RECEPTORS, GLUTAMATE; SIGNAL TRANSDUCTION; SUBSTANCE P;

EID: 65049092155     PISSN: 01497634     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neubiorev.2009.02.005     Document Type: Review

References (213)

1. Acquas E., and Di Chiara G. Depression of mesolimbic dopamine transmission and sensitization to morphine during opiate abstinence. J. Neurochem. 58 (1992) 1620-1625
2. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. (1994), American Psychiatric Press, Washington, DC
3. Berhow M.T., Hiroi N., and Nestler E.J. Regulation of ERK (extracellular signal regulated kinase), part of the neurotrophin signal transduction cascade, in the rat mesolimbic dopamine system by chronic exposure to morphine or cocaine. J. Neurosci. 16 (1996) 4707-4715
4. Bisaga A., Comer S.D., and Ward A.S. The NMDA antagonist memantine attenuates the expression of opioid physical dependence in humans. Psychopharmacology 157 (2001) 1-10
5. Bjorklund A., and Dunnett S.B. Dopamine neuron systems in the brain: an update. Trends Neurosci. 30 (2007) 194-202
6. Blaha C.D., Yang C.R., Floresco S.B., Barr A.M., and Phillips A.G. Stimulation of the ventral subiculum of the hippocampus evokes glutamate receptor-mediated changes in dopamine efflux in the rat nucleus accumbens. Eur. J. Neurosci. 9 (1997) 902-911
7. Bonci A., and Williams J.T. Increased probability of GABA release during withdrawal from morphine. J. Neurosci. 17 (1997) 796-803
8. Bouyer J.J., Park D.H., Joh T.H., and Pickel V.M. Chemical and structural analysis of the relation between cortical inputs and tyrosine hydroxylase-containing terminals in rat neostriatum. Brain Res. 302 (1984) 267-275
9. Bredt D.S., and Snyder S.H. Nitric oxide, a novel neuronal messenger. Neuron 8 (1992) 3-11
10. Bristow L.J., Hogg J.E., and Hutson P.H. Competitive and glycine/NMDA receptor antagonists attenuate withdrawal-induced behaviours and increased hippocampal acetylcholine efflux in morphine-dependent rats. Neuropharmacology 36 (1997) 241-250
11. Buccafusco J.J., Terry Jr. A.V., and Shuster L. Spinal NMDA receptor-nitric oxide mediation of the expression of morphine withdrawal symptoms in the rat. Brain Res. 679 (1995) 189-199
12. Cai Y.C., Ma L., Fan G.H., Zhao J., Jiang L.Z., and Pei G. Activation of N-methyl-d-aspartate receptor attenuates acute responsiveness of δ-opioid receptors. Mol. Pharmacol. 51 (1997) 583-587
13. Carlton S.M., Zhou S., and Coggeshall R.E. Evidence for the interaction of glutamate and NK1 receptors in the periphery. Brain Res. 790 (1998) 160-169
14. Carr D.B., and Sesack S.R. Projections from the rat prefrontal cortex to the ventral tegmental area: target specificity in the synaptic associations with mesoaccumbens and mesocortical neurons. J. Neurosci. 20 (2000) 3864-3873
15. Chang L., and Karin M. Mammalian MAP kinase signalling cascades. Nature 410 (2001) 37-40
16. Chang J.Y., Zhang L.L., Janak P.H., and Woodward D.J. Neuronal responses in prefrontal cortex and nucleus accumbens during heroin self-administration in freely moving rats. Brain Res. 754 (1997) 12-20
17. Chen Z., Gibson T.B., Robinson F., Silvestro L., Pearson G., Xu B.E., Wright A., Vanderbilt C., and Cobb M.H. MAP kinases. Chem. Rev. 101 (2001) 2449-2476
18. Chergui K., Charlety P.J., Akaoka H., Saunier C.F., Brunet J.L., Buda M., Svensson T.H., and Chouvet G. Tonic activation of NMDA receptors causes spontaneous burst discharge of rat midbrain dopamine neurons in vivo. Eur. J. Neurosci. 5 (1993) 137-144
19. Choe E.S., Chung K.T., Mao L., and Wang J.Q. Amphetamine increases phosphorylation of extracellular signal regulated kinase and transcription factors in the rat striatum via group I metabotropic glutamate receptors. Neuropsychopharmacology 27 (2002) 565-575
20. Chuang L.F., Killam K.F., and Chuang R.Y. Induction and activation of mitogen-activated protein kinases of human lymphocytes as one of the signaling pathways of the immunomodulatory effects of morphine sulfate. J. Biol. Chem. 272 (1997) 26815-26817
21. Chuhma N., Zhang H., Masson J., Zhuang X., Sulzer D., Hen R., and Rayport S. Dopamine neurons mediate a fast excitatory signal via their glutamatergic synapses. J. Neurosci. 24 (2004) 972-981
22. Conn P.J., and Desai M.A. Pharmacology and physiology of metabotropic glutamate receptors in mammalian central nervous system. Drug Dev. Res. 24 (1991) 207-229
23. Conn P.J., and Pin J.P. Pharmacology and functions of metabotropic glutamate receptors. Annu. Rev. Pharmacol. Toxicol. 37 (1997) 205-237
24. Cotman C.W., Monaghan D.T., Ottersen O.P., and Storm-Mathisen J. Anatomical organization of excitatory amino acid receptors and their pathway. Trends Neurosci. 10 (1987) 273-280
25. Coutinho V., and Knopfel T. Metabotropic glutamate receptors: electrical and chemical signaling properties. Neuroscientist 8 (2002) 551-561
26. Dackis C.A., and Gold M.S. New concepts in cocaine addiction: the dopamine depletion hypothesis. Neurosci. Biobehav. Rev. 9 (1985) 469-477
27. Davis R.J. Signal transduction by the JNK group of MAP kinases. Cell 103 (2000) 239-252
28. De Vries T.J., and Shippenberg T.S. Neural system underlying opiate addiction. J. Neurosci. 22 (2002) 3321-3325
29. Di Chiara, and Imperato G.A. Drug abused by human preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc. Natl. Acad. Sci. U.S.A. 85 (1998) 5274-5278
30. Di Chiara G. The role of dopamine in drug abuse viewed from the perspective of its role in motivation. Drug Alcohol Depend. 38 (1995) 95-137
31. Di Ciano P., Cardinal R.N., Cowell R.A., Little S.J., and Eceritt B.J. Differential involvement of NMDA, AMPA/kainate, and dopamine receptors in the nucleus accumbens core in the acquisition and performance of Pavlovian approach behavior. J. Neurosci. 21 (2001) 9471-9477
32. Dingledine R., Borges K., Bowie D., and Traynelis S.F. The glutamate receptor ion channels. Pharmacol. Rev. 51 (1999) 7-62
33. Dougherty P.M., Palecek J., Zorn S., and Willis W.D. Combined application of excitatory amino acids and substance P produces long-lasting changes in responses of primate spinothalamic tract neurons. Brain Res. Brain Res. Rev. 18 (1993) 227-246
34. Elliot K., Kest B., Man A., Kao B., and Inturissi C.E. N-methyl-d-aspartate (NMDA) receptors, mu and kappa opioid tolerance, and perspectives on new analgesic drug development. Neuropsychopharmacology 13 (1995) 347-356
35. Etoh S., Baba A., and Iwata H. NMDA induces protein kinase C translocation in guinea pig cerebral synaptoneurosomes. Jpn. J. Pharmacol. 56 (1991) 287-296
36. Etoh S., Baba A., and Iwata H. NMDA induces protein kinase C translocation in hippocampal slices of immature rat brain. Neurosci. Lett. 126 (1991) 119-122
37. Everitt B.J., Dickinson A., and Robbins T.W. The neuropsychological basis of addictive behaviour. Brain Res. Rev. 36 (2001) 129-138
38. Fallon J.H., and Moore R.Y. Catecholamine innervation of the basal forebrain. IV. Topography of the dopamine projection to the basal forebrain and neostriatum. J. Comp. Neurol. 180 (1978) 545-580
39. Fan G.H., Zhao J., Wu Y.L., Lou L.G., Zhang Z., Jing Q., Ma L., and Pei G. N-methyl-d-aspartate attenuates opioid receptor-mediated G protein activation and this process involves protein kinase C. Mol. Pharmacol. 53 (1998) 684-690
40. Fields H.L., Hjelmstad G.O., Margolis E.B., and Nicola S.M. Ventral tegmental area neurons in learned appetitive behavior and positive reinforcement. Annu. Rev. Neurosci. 30 (2007) 289-316
41. Fitzgerald L.W., Ortiz J., Hamedani A.G., and Nestler E.J. Drugs of abuse and stress increase the expression of GluR1 and NMDAR1 glutamate receptor subunits in the rat ventral tegmental area: common adaptations among cross-sensitizing agents. J. Neurosci. 16 (1996) 274-282
42. Floresco S.B., Blaha C.D., Yang C.R., and Phillips A.G. Dopamine D1 and NMDA receptors mediate potentiation of basolateral amygdala-evoked firing of nucleus accumbens neurons. J. Neurosci. 21 (2001) 6370-6376
43. Floresco S.B., Yang C.R., Phillips A.G., and Blaha C.D. Basolateral amygdala stimulation evokes glutamate receptor-dependent dopamine efflux in the nucleus accumbens of the anaesthetized rat. Eur. J. Neurosci. 10 (1998) 1241-1251
44. Fonnum F. Glutamate: a neurotransmitter in mammalian brain. J. Neurochem. 42 (1984) 1-11
45. Freeman W.F., Brebner K., Lynch W.J., Robertson D.J., Roberts D.C.S., and Vrana K.E. Cocaine-responsive gene expression changes in rat hippocampus. Neuroscience 108 (2001) 371-380
46. Fundytus M.E., and Coderre T.J. Effect of activity at metabotropic, as well as ionotropic (NMDA), glutamate receptors on morphine dependence. Br. J. Pharmacol. 113 (1994) 1215-1220
47. Gabra B.H., Afify E.A., Daabees T.T., and Zeit-Har M.S.A. The role of the NO/NMDA pathways in the development of morphine withdrawal induced by naloxone in vitro. Pharmacol. Res. 51 (2005) 319-327
48. Gadd C.A., Murtra P., Felipe C.D., and Hunt S.P. Neurokinin-1 receptor-expressing neurons in the amygdala modulate morphine reward and anxiety behaviors in the mouse. J. Neurosci. 23 (2003) 8271-8280
49. Gass J.T., and Olive M.F. Glutamatergic substrates of drug addiction and alcoholism. Biochem. Pharmacol. 75 (2008) 218-265
50. Geisler S., Derst C., Veh R.W., and Zahm D.S. Glutamatergic afferents of the ventral tegmental area in the rat. J. Neurosci. 27 (2007) 5730-5743
51. Gerdjikov T.V., Ross G.M., and Beninger R.J. Place preference induced by nucleus accumbens amphetamine is impaired by antagonists of ERK or p38 MAP kinases in rats. Behav. Neurosci. 118 (2004) 740-750
52. Glass M.J., Lane D.A., Colago E.E.O., Chan J., Schlussman S.D., Zhou Y., Kreek M.J., and Pickel V.M. Chronic administration of morphine is associated with a decrease in surface AMPA GluR1 receptor subunit in dopamine D1 receptor expressing neurons in the shell and non-D1 receptor expressing neurons in the core of the rat nucleus accumbens. Exp. Neurol. 210 (2008) 750-761
53. Goldman-Rakic P.S. The physiological approach: functional architecture of working memory and disordered cognition in schizophrenia. Biol. Psychiatry 46 (1999) 650-661
54. Goldstein R.A., and Volkow N.D. Drug addiction and its underlying neurobiological basis: neuroimaging evidence for the involvement of the frontal cortex. Am. J. Psychiatry 159 (2002) 1642-1652
55. Grace A.A., and Bunney B.S. The control of firing pattern in nigral dopamine neurons: single spike firing. J. Neurosci. 4 (1984) 2866-2876
56. Grant S., London E.D., and Newlin D.B. Activation of memory circuits during cue-elicited cocaine craving. PNAS 93 (1996) 12040-12045
57. Groenewegen H.J., Vermeulen-Van der Zee E., te Kortschot A., and Witter M.P. Organization of the projections from the subiculum to the ventral striatum in the rat. A study using anterograde transport of Phaseolus vulgaris-leucoagglutinin. Neuroscience 23 (1987) 103-112
58. Groenewegen H.J., Wright C.I., Beijer A.V., and Voorn P. Convergence and segregation of ventral striatal inputs and outputs. Ann. N.Y. Acad. Sci. 877 (1999) 49-63
59. Guan J.S., Xu Z.Z., Gao H., He S.Q., Ma G.Q., Sun T., Wang L.H., Zhang Z.N., Lena I., Kitchen I., Elde R., Zimmer A., He C., Pei G., Bao L., and Zhang X. Interaction with vesicle luminal protachykinin regulates surface expression of delta-opioid receptors and opioid analgesia. Cell 122 (2005) 619-631
60. 3H] MK-801 to brain regions and spinal cord of the rat. Brain Res. 639 (1994) 269-274
61. Guitart X., Thompson M.A., Mirante C.K., Greenberg M.E., and Nestler E.J. Regulation of cyclic AMP response element-binding protein (CREB) phosphorylation by acute and chronic morphine in the rat locus coeruleus. J. Neurochem. 58 (1992) 1168-1171
62. Harris G.C., and Aston-Jones G. Involvement of D2 dopamine receptors in the nucleus accumbens in the opiate withdrawal syndrome. Nature 371 (1994) 155-157
63. Hayward M.D., Duman R.S., and Nestler E.J. Induction of the c-fos protooncogene during opiate withdrawal in the locus coeruleus and other regions of rats brain. Brain Res. 525 (1990) 256-266
64. Headley P.M., and Grillner S. Excitatory amino acids and synaptic transmission: the evidence for a physiological function. Trends Pharmacol. Sci. 11 (1990) 205-211
65. Heimer L., Alheid G.F., de Olmos J.S., Groenewegen H.J., Haber S.N., Harlan R.E., and Zahm D.S. The accumbens: beyond the coreshell dichotomy. J. Neuropsychiatry Clin. Neurosci. 9 (1997) 354-381
66. Hermans E., and Challiss R.A. Structural, signalling and regulatory properties of the group I metabotropic glutamate receptors: prototypic family C G-protein-coupled receptors. Biochem. J. 359 (2001) 465-484
67. Herz A., Shippenberg T.S., Bals-kubik R., and Spanagel R. Opiate addiction: pharmacologic and biochemical aspects. Arzeimittelforschung 42 (1992) 256-259
68. Hu J.H., Yang N., and Ma Y.H. Decrease of morphine-induced reward effects and withdrawal symptoms in mice overexpressing gamma-aminobutyric acid transporter I. J. Neurosci. Res. 74 (2003) 614-621
69. Ivanov A., and Aston-Jones G. Local opiate withdrawal in locus coeruleus neurons in vitro. Neurophysiology 85 (2001) 2388-2397
70. Jenab S., Festa E.D., Nazarian A., Wu H.B., Sun W.L., Hazim R., Russo S.J., and Quinones-Jenab V. Cocaine induction of ERK proteins in dorsal striatum of Fischer rats. Mol. Brain Res. 142 (2005) 134-138
71. Jingami H., Nakanishi S., and Morikawa K. Structure of the metabotropic glutamate receptor. Curr. Opin. Neurobiol. 13 (2003) 271-278
72. Johnson G.L., and Lapadat R. Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases. Science 298 (2002) 1911-1912
73. Johnson S.W., and North R.A. Opioids excite dopamine neurons by hyperpolarization of local interneurons. J. Neurosci. 12 (1992) 483-488
74. Jongen-Relo A.L., Groenewegen H.J., and Voorn P. Evidence for a multi-compartmental histochemical organization of the nucleus accumbens in the rat. J. Comp. Neurol. 337 (1993) 267-276
75. Jongen-Relo A.L., Voorn P., and Groenewegen H.J. Immunohistochemical characterization of the shell and core territories of the nucleus accumbens in the rat. Eur. J. Neurosci. 6 (1994) 1255-1264
76. Kalivas P.W., and Duffy P. Repeated cocaine administration alters extracellular glutamate in the ventral tegmental area. J. Neurochem. 70 (1998) 1497-1502
77. Kalivas P.W., LaLumiere R.T., Knackstedt L., and Shen H. Glutamate transmission in addiction. Neuropharmacolgy 56 (2009) 169-173
78. Kalivas P.W., and O'Brien C. Drug addiction as a pathology of staged neuroplasticity. Neuropsychopharmacology 33 (2008) 166-180
79. Kalivas P.W., and Volkow N.D. The neural basis of addiction: a pathology of motivation and choice. Focus 5 (2007) 208-219
80. Kalivas P.W. Glutamate system in cocaine addiction. Curr. Opin. Pharmacol. 4 (2004) 23-29
81. Kalivas P.W. Neurotransmitter regulation of dopamine neurons in the ventral tegmental area. Brain Res. Rev. 18 (1993) 75-113
82. Kelley A.E., Domesick V.B., and Nauta W.J.H. The amygdalostriatal projection in the rat-an anatomical study by anterograde and retrograde tracing methods. Neuroscience 7 (1982) 615-630
83. Kenny P.J., and Markou A. The ups and downs of addiction: role of metabotropic glutamate receptors. Trends Pharmacol. Sci. 25 (2004) 265-272
84. Kiyatkin E.A., and Rebee G.V. Impulse activity of ventral tegmental area neurons during heroin self-administration in rats. Neuroscience 102 (2001) 565-580
85. Kombian S.B., Ananthalakshmi K.V., Parvathy S.S., and Matowe W.C. Dopamine and adenosine mediate substance P-induced depression of evoked IPSCs in the rat nucleus accumbens in vitro. Eur. J. Neurosci. 18 (2003) 303-311
86. Koob G.F., Ahmed S.H., Boutrel H., Chen S.A., Kenny P.J., Markou A., O'Dell L.E., Parsons L.H., and Sanna P.P. Neurobiological mechanisms in the transition from drug use to drug dependence. Neurosci. Biobehav. Rev. 27 (2004) 739-749
87. Koob G.F., and Nestler E.J. The neurobiology of drug addiction. J. Neuropsychiatry Clin. Neurosci. 9 (1997) 482-497
88. Koob G.F., Sanna P.P., and Bloom F.E. Neuroscience of addiction. Neuron 21 (1998) 467-476
89. Koob G.F. Drug of abuse: anatomy, pharmacology and function of reward pathways. Trends Pharmacol. Sci. 13 (1992) 177-184
90. Koob G.F. Neuroadaptive mechanisms of addiction: studies on the extended amygdala. Eur. Neuropsychopharmacol. 13 (2003) 442-452
91. Kotecha S.A., and MacDonald J.F. Signaling molecules and receptor transduction cascades that regulate NMDA receptor-mediated synaptic transmission. Int. Rev. Neurobiol. 54 (2003) 51-106
92. Koyuncuoglu H., Nurten A., Yamanturk P., and Nurten R. The importance of the number of NMDA receptors in the development of supersensitivity or tolerance to and dependence on morphine. Pharmacol. Res. 39 (1999) 311-319
93. Kretschmer B.D. Modulation of the mesolimbic dopamine system by glutamate: role of NMDA receptor. J. Neurochem. 73 (1999) 839-848
94. Lapish C.C., Seamans J.K., and Chandler L.J. Glutamate-dopamine cotransmission and reward processing in addiction. Alcohol. Clin. Exp. Res. 30 (2006) 1451-1465
95. Lavin A., Nogueira L., Lapish C.C., Wightman R.M., Phillips P.E., and Seamans J.K. Mesocortical dopamine neurons operate in distinct temporal domains using multimodal signaling. J. Neurosci. 25 (2005) 5013-5023
96. Li L.Y., and Chang K.J. The stimulatory effect of opioids on mitogen-activated protein kinase in Chinese hamster ovary cells transfected to express mu-opioid receptors. Mol. Pharmacol. 50 (1996) 599-602
97. Li X., Gardner E.L., and Xi Z.X. The metabotropic glutamate receptor 7 (mGluR7) allosteric agonist AMN082 modulates nucleus accumbens GABA and glutamate, but not dopamine, in rats. Neuropharmacology 54 (2008) 542-551
98. Lizasoain I., Leza J.C., Cuellar B., Moro M.A., and Lorenzo P. Inhibition of morphine withdrawal by lamotrigine: involvement of nitric oxide. Eur. J. Pharmacol. 299 (1996) 41-45
99. Lu L., Hope B.T., Dempsey J., Liu S.Y., Bossert J.M., and Shaham Y. Central amygdale ERK signaling pathway is critical to incubation of cocaine craving. Nat. Neurosci. 8 (2005) 212-219
100. Madden D.R. The structure and function of glutamate receptor ion channels. Nat. Rev. Neurosci. 3 (2002) 91-101
101. Manning B.H., Mao J., Frenk H., Price D.D., and Mayer D.J. Continuous co-administration of dextromethorphan or MK-801 with morphine: attenuation of morphine dependence and naloxone-reversible attenuation of morphine tolerance. Pain 67 (1996) 79-88
102. Mansour A., Khachaturian H., Lewis M.E., Akil H., and Watson S.J. Autoradiographic differentiation of m, d, and k opioid receptors in the rat forebrain and midbrain. J. Neurosci. 7 (1987) 2445-2464
103. Manzanares J., Corchero J., Romero J., Fernandez-Ruiz J.J., Ramos J.A., and Fuentes J.A. Pharmacological and biochemical interactions between opioids and cannabinoids. Trends Pharmacol. Sci. 20 (1999) 287-294
104. Mao J., Price D.D., Phillips L.L., Lu J., and Mayer D.J. Increases in protein kinase C gamma immunoreactivity in the spinal cord of rats associated with tolerance to the analgesic effects of morphine. Brain Res. 677 (1995) 257-267
105. Mao L., Tang Q., Samdani S., Liu Z., and Wang J.Q. Regulation of MAPK/ERK phosphorylation via ionotropic glutamate receptors in cultured rat striatal neurons. Eur. J. Neurosci. 19 (2004) 1207-1216
106. Margolis E.B., Lock H., Hjelmstad G.O., and Fields H.L. The ventral tegmental area revisited: is there an electrophysiological marker for dopaminergic neurons?. J. Physiol. 577 (2006) 907-924
107. Markou A. The role of metabotropic glutamate receptors in drug reward, motivation and dependence. Drug News Perspect. 20 (2007) 103-108
108. Mayer D.J., Mao J., and Price D.D. The development of morphine tolerance and dependence is associated with translocation of protein kinase C. Pain 61 (1995) 365-374
109. McLaughlin J., and See R.E. Selective inactivation of the dorsomedial prefrontal cortex and the basolateral amygdala attenuates conditioned-cued reinstatement of extinguished cocaine-seeking behavior in rats. Psychopharmacology (Berl) 168 (2003) 57-65
110. McLean S., Rothman R.B., and Herkenham M. Autoradiographic localization of m- and d-opiate receptors in the forebrain of the rat. Brain Res. 378 (1986) 49-60
111. Meredith G.E., Pattiselanno A., Groenewegen H.J., and Haber S.N. Shell and core in monkey and human nucleus accumbens identified with antibodies to calbindin-D28k. J. Comp. Neurol. 365 (1996) 628-639
112. Miller R.J. G-protein linked glutamate receptor. Semin. Neurosci. 6 (1994) 105-115
113. Mitrano D.A., and Smith Y. Comparative analysis of the subcellular and subsynaptic localization of mGluR1a and mGluR5 metabotropic glutamate receptors in the shell and core of the nucleus accumbens in rat and monkey. J. Comp. Neurol. 500 (2007) 788-806
114. Mitrano D.A., Arnold C., and Smith Y. Subcellular and subsynaptic localization of group I metabotropic glutamate receptors in the nucleus accumbens of cocaine-treated rats. Neuroscience 154 (2008) 653-666
115. Modafferi A.M., Diana M., Nicoletti F., and Scaccianoce S. Morphine withdrawal increases metabotropic glutamate 2/3 receptors expression in nucleus accumbens. Neuroreport 19 (2008) 911-914
116. Monaghan D.T., Bridges R.J., and Cotman C.W. The excitatory amino acid receptors: their classes, pharmacology, and distinct properties in the function of the central nervous system. Annu. Rev. Pharmacol. Toxicol. 29 (1989) 365-402
117. Monyer H., Spregel R., Schoepfer R., Herb A., Hihuchi M., Lomeli H., Burnashev N., Sakmann B., and Seeburg P.H. Heteromeric NMDA receptors: molecular and functional distinction of subtypes. Science 256 (1992) 1217-1221
118. Mudo G., Trovato-Salinaro A., Caniglia G., Cheng Q., and Condorelli D.F. Cellular localization of mGluR3 and mGluR5 mRNAs in normal and injured rat brain. Brain Res. 1149 (2007) 1-13
119. Murase S., Grenhoff J., Chouvet G., Gonon F.G., and Svensson T.H. Prefrontal cortex regulates burst firing and transmitter release in rat mesolimbic dopamine neurons studied in vivo. Neurosci. Lett. 157 (1993) 53-56
120. Myers S.J., Dingledine R., and Borges K. Genetic regulation of glutamate receptor ion channels. Annu. Rev. Pharmacol. Toxicol. 39 (1999) 221-241
121. Nakanishi S. Molecular diversity of glutamate receptors and implications for brain functions. Science 258 (1992) 597-603
122. Narayanan S., Willam D., and Dalia A. Role of dopaminergic mechanisms in the stimulatory effects of MK-801 injected into the ventral tegmental area and the nucleus accumbens. Pharmcol. Biochem. Behav. 54 (1995) 565-573
123. Narita M., Narita M., Mizoguchi H., and Tseng L.F. Inhibition of protein kinase C, but not of protein kinase A, blocks the development of acute antinociceptive tolerance to an intrathecally administered mu-opioid receptor agonist in the mouse. Eur. J. Pharmacol. 280 (1995) R1-R3
124. Nestler E.J., and Aghajanian G.K. Molecular and cellular basis of addiction. Science 278 (1997) 58-63
125. Nestler E.J., Hyman S.E., and Malenka R.C. Molecular Neuropharmacology: A Foundation for Clinical Neuroscience (2001), McGraw-Hill, New York
126. Noda Y., Mamiya T., and Nabeshima T. The mechanisms of morphine dependence and it's withdrawal syndrome: study in mutant mice. Nippon Yakurigaku Zasshi 117 (2001) 21-26
127. Noda Y., Yamada K., Komori Y., Sugihara H., Furukawa H., and Nabeshima T. Role of nitric oxide in the development of tolerance and sensitization to behavioural effects of phencyclidine in mice. Br. J. Pharmacol. 117 (1996) 1579-1585
128. Nutt D., Lingford-Hughes A., and Daglish M. Future directions in substance dependence research. J. Neural Transm. Suppl. 64 (2003) 95-103
129. O'Donnell P., and Grace A.A. Physiological and morphological properties of accumbens core and shell neurons recorded in vitro. Synapse 13 (1993) 135-160
130. Otsuka M., and Yoshioka K. Neurotransmitter functions of mammalian tachykinins. Physiol. Rev. 73 (1993) 229-308
131. Palucha A., Branski P., and Pilc A. Selective mGlu5 receptor antagonist MTEP attenuates naloxone-induced morphine withdrawal symptoms. Pol. J. Pharmacol. 56 (2004) 863-866
132. Paoletti P., and Neyton J. NMDA receptor subunits: function and pharmacology. Curr. Opin. Pharmacol. 7 (2007) 39-47
133. Parelkar N.K., and Wang J.Q. Upregulation of metabotropic glutamate receptor 8 mRNA expression in the rat forebrain after repeated amphetamine administration. Neurosci. Lett. 433 (2008) 250-254
134. Paul J.K., and Athina M. The ups and downs of addiction: role of metabotropic glutamate receptors. Trends Pharmacol. Sci. 25 (2004) 265-272
135. Pennartz C.M., Groenewegen H.J., and Lopes daSilva F.H. The nucleus accumbens as a complex of functionally distinct neuronal ensembles: an integration of behavioural, electrophysiological and anatomical data. Prog. Neurobiol. 42 (1994) 719-761
136. 2+-permeable AMPA receptors induce phosphorylation of cAMP response element-binding protein through a phosphatidylinositol 3-kinase dependent stimulation of the mitogen-activated protein kinase signaling cascade in neurons. J. Neurosci. 19 (1999) 5861-5874
137. Peters J., and Kalivas P.W. The group II metabotropic glutamate receptor agonist, LY379268, inhibits both cocaine- and food-seeking behavior in rats. Psychopharmacology 186 (2006) 143-149
138. Phillipson O.T., and Griffiths A.C. The topographic order of inputs to nucleus accumbens in the rat. Neuroscience 16 (1985) 275-296
139. Pierce R.C., and Kalivas P.W. A circuitry model of the expression of behavioral sensitization to amphetamine-like psychostimulants. Brain Res. Rev. 25 (1997) 192-216
140. Pierce R.C., Pierce-Bancroft A.F., and Prasad B.M. Neurotrophin-3 contributes to the initiation of behavioral sensitization to cocaine by activating the Ras/mitogen-activated protein kinase signal transduction cascade. J. Neurosci. 19 (1999) 8685-8695
141. Pin J.P., and Acher F. The metabotropic glutamate receptors: structure, activation mechanism and pharmacology. Curr. Drug Target CNS Neurol. Disord. 1 (2002) 297-317
142. Pin J.P., and Duvoisin R. Review: neurotransmitter receptors. I. The metabotropic glutamate receptors: structure and function. Neuropharmacology 34 (1995) 1-26
143. Popik P., and Kolasiewicz W. Mesolimbic NMDA receptors are implicated in the expression of conditioned morphine reward. Naunyn-Schmiedebergs Arch. Pharmacol. 359 (1999) 288-294
144. Popik P., Mamczarz J., Fraczek M., Widla G., Hesselink M., and Danysz W. Inhibition of reinforcing effects of morphine and naloxone-precipitated opioid withdrawal by novel glycine site and uncompetitive NMDA receptor antagonists. Neuropharmacology 37 (1998) 1033-1042
145. Radwanska K., Caboche J., and Kaczmarek L. Extracellular signal-regulated kinase (ERKs) modulate cocaine-induced gene expression in the mouse amygdala. Eur. J. Neurosci. 22 (2005) 939-948
146. Rasmussen K. The role of the locus coeruleus and N-methyl-d-aspartic acid (NMDA) and AMPA receptors in opiate withdrawal. Neuropsychopharmacology 13 (1995) 295-300
147. Ree V.J.M., Gerrits M.A.F.M., and Vanderschuren L.J.M.J. Opioids, reward and addiction: an encounter of biology, psychology, and medicine. Pharmacol. Rev. 51 (1999) 341-396
148. Robbe D. Metabotropic glutamate receptor 2/3-dependent long-term depression in the nucleus accumbens is blocked in morphine withdrawn mice. Eur. J. Neurosci. 16 (2002) 2231-2235
149. Rong R., Ahn J.Y., Huang H., Nagata E., Kalman D., Kapp J.A., Tu J., Worley P.F., Snyder S.H., and Ye K. PI3 kinase enhancer-Homer complex couples mGluRI to PI3 kinase, preventing neuronal apoptosis. Nat. Neurosci. 6 (2003) 1153-1161
150. Roux P.P., and Blenis J. ERK and p38 MAPK-activated protein kinases: a family of protein kinases with diverse biological functions. Microbiol. Mol. Biol. Rev. 68 (2004) 320-344
151. Schoepp D.D., Bockaert J., and Sladeczek F. Pharmacology and functional characteristics of metabotropic excitatory amino acid receptors. Trends Pharmacol. Sci. 11 (1990) 508-515
152. Schoepp D.D. Unveiling the functions of presynaptic metabotropic glutamate receptors in the central nervous system. J. Pharmacol. Exp. Ther. 299 (2001) 12-20
153. Schoffelmeer A.N., Wardeh G., and Vanderschuren L.J. Morphine acutely and persistently attenuates non-vesicular GABA release in rat nucleus accumbens. Synapse 42 (2001) 87-94
154. Schotanus S.M., and Chergui K. Dopamine D1 receptors and group I metabotropic glutamate receptors contribute to the induction of long-term potentiation in the nucleus accumbens. Neuropharmacology 54 (2008) 837-844
155. See R.E., Fuchs R.A., Ledford C.C., and McLaughlin J. Drug addiction, relapse, and the amygdala. Ann. N.Y. Acad. Sci. 985 (2003) 294-307
156. Seeburg P.H. The molecular biology of glutamate receptor channels. Trends Pharmacol. Sci. 14 (1993) 297-303
157. Shaham Y., Rajabi H., and Stewart J. Relapse to heroin-seeking in rats under opioid maintenance: the effects of stress, heroin priming, and withdrawal. J. Neurosci. 16 (1996) 1957-1963
158. Shi X., and McGinty J.F. Extracellular signal-regulated mitogen-activated protein kinase inhibitors decrease amphetamine-induced behavior and neuropeptide gene expression in the striatum. Neuroscience 138 (2006) 1289-1298
159. Spanagel R., and Weiss F. The dopamine hypothesis of reward: past and current status. Trends Neurosci. 22 (2002) 521-527
160. Spiga S., Serra G.P., Puddu M.C., Foddai M., and Diana M. Morphine withdrawal-induced abnormalities in the VTA: confocal laser scanning microscopy. Eur. J. Neurosci. 17 (2003) 605-612
161. A receptors. Biochem. Soc. Trans. 34 (2006) 877-881
162. Suaud-Chagny M.F., Chergui K., Chouvet G., and Gonon F. Relationship between dopamine release in the rat nucleus accumbens and the discharge activity of dopaminergic neurons during local in vivo application of amino acids in the ventral tegmental area. Neuroscience 49 (1992) 63-72
163. Sucher N.J., Awobuluyi M., Choi Y.B., and Lipton S.A. NMDA receptors: from genes to channels. Trends Pharmacol. Sci. 17 (1996) 348-555
164. Svensson L., Zhang J., Johannessen K., and Engel J.A. Effect of local infusion of glutamate analogues into the nucleus accumbens of rats: an electrochemical and behavioural study. Brain Res. 643 (1994) 155-161
165. Swanson L.W. The projections of the ventral tegmental area and adjacent regions: a combined fluorescent retrograde tracer and immunofluorescence study in the rat. Brain Res. Bull. 9 (1982) 321-353
166. Swanson C.J., and Kalivas P.W. Regulation of locomotor activity by metabotropic glutamate receptors in the nucleus accumbens and ventral tegmental area. J. Pharmacol. Exp. Ther. 292 (2000) 406-414
167. Temple A., and Zukin R.S. Neuroanatomical patterns of the μ, δ, and κ opioid receptors of rat brain as determined by quantitative in vitro autoradiography. Proc. Natl. Acad. Sci. U.S.A. 84 (1987) 4308-4312
168. Tingley W.G., Ehlers M.D., Kameyama K., Doherty C., Ptak J.B., Riley C.T., and Huganir R.L. Characterization of protein kinase A and protein kinase C phosphorylation of the N-methyl-d-aspartate receptor NR1 subunit using phosphorylation site-specific antibodies. J. Biol. Chem. 272 (1997) 5157-5166
169. Tokuyama S., Wakabayashi H., and Ho I.K. Direct evidence for a role of glutamate in the expression of the opioid withdrawal syndrome. Eur. J. Pharmacol. 295 (1996) 123-129
170. Tokuyama S., Zhu H., Oh S., Ho I.K., and Yamamoto T. Further evidence for a role of NMDA receptors in the locus coeruleus in the expression of withdrawal syndrome from opioids. Neurochem. Int. 39 (2001) 103-109
171. Tonini R., Ciardo S., Cerovic M., Rubino T., Parolaro D., Mazzanti M., and Zippel R. ERK-dependent modulation of cerebellar synaptic plasticity after chronic Δ9-tetrahydrocannabinol exposure. J. Neurosci. 26 (2006) 5810-5818
172. Trujillo K.A., and Akil H. Inhibition of morphine tolerance and dependence by the NMDA receptor antagonist MK-801. Science 251 (1991) 85-87
173. B receptors inhibits morphine-induced place preference in rats. Eur. J. Pharmacol. 313 (1996) 169-173
174. Tzschentke T.M., and Schmidt W.J. Functional relationship among medial prefrontal cortex, nucleus accumbens, and ventral tegmental area in locomotion and reward. Crit. Rev. Neurobiol. 14 (2000) 131-142
175. Tzschentke T.M., and Schmidt W.J. Glutamatergic mechanisms in addiction. Mol. Psychiatry 8 (2003) 373-382
176. Tzschentke T.M. Pharmacology and behavioral pharmacology of the mesocortical dopamine system. Prog. Neurobiol. 63 (2001) 241-320
177. Ungless M.A., Whistber J.L., Malenka R., and Bonci A. Single cocaine exposure in vivo induces long-term potentiation in dopamine neurons. Nature 411 (2001) 583-587
178. Valjent E., Corbille A.G., Bertran-Gonzalez J., Herve D., and Girault J.A. Inhibition of ERK pathway or protein synthesis during reexposure to drugs of abuse erases previously learned place preference. Proc. Natl. Acad. Sci. U.S.A. 103 (2006) 2932-2937
179. Valjent E., Corvol J.C., Pages C., Besson M.J., Maldonado R., and Caboche J. Involvement of the extracellular signal-regulated kinase cascade for cocaine-rewarding properties. J. Neurosci. 20 (2000) 8701-8709
180. Valjent E., Pascoli V., Svenningsson P., Paul S., Enslen H., Corvol J., Stipanovich A., Caboche J., Lombroso P.J., Nairn A.C., Greengard P., Hervé D., and Girault J. Regulation of a protein phosphatase cascade allows convergent dopamine and glutamate signals to activate ERK in the striatum. Proc. Natl. Acad. Sci. U.S.A. 102 (2005) 491-496
181. Van Bockstaele E.J., and Pickel V.M. GABA-containing neurons in the ventral tegmental area project to the nucleus accumbens in rat brain. Brain Res. 682 (1995) 215-221
182. Vaupel D.B., Kimes A.S., and London E.D. Further in vivo studies on attenuating morphine withdrawal: isoform-selective nitric oxide synthase inhibitors differ in efficacy. Eur. J. Pharmacol. 324 (1997) 11-20
183. Voorn P., Brady L.S., Schotte A., Berendse H.W., and Richfield E.K. Evidence for two neurochemical divisions in the human nucleus accumbens. Eur. J. Neurosci. 6 (1994) 1913-1916
184. Wang B., Luo F., Ge X.C., Fu A.H., and Han J.S. Effects of lesions of various brain areas on drug priming or footshock-induced reactivation of extinguished conditioned place preference. Brain Res. 950 (2002) 1-9
185. Wang H.L., Xiang X.H., Guo Y., Wu W.R., Cao D.Y., Wang H.S., and Zhao Y. Ionotropic glutamatergic neurotransmission in the ventral tegmental area modulates ΔFosB expression in the nucleus accumbens and abstinence syndrome in morphine withdrawal rats. Eur. J. Pharmacol. 527 (2005) 94-104
186. Wang H.L., Zhao Y., Xiang X.H., Wang H.S., and Wu W.R. Blockade of ionotropic glutamatergic transmission in the ventral tegmental area attenuates the physical signs of morphine withdrawal in rats. Prog. Neuropsychopharmacol. Biol. Psychiatry 28 (2004) 1079-1087
187. Wang J.Q., Fibuch E.E., and Mao L. Regulation of mitogen-activated protein kinases by glutamate receptors. J. Neurochem. 100 (2007) 1-11
188. Wang J.Q., Tang Q., Parelkar N.K., Liu Z., Samdani S., Choe E.S., Yang L., and Mao L. Glutamate signaling to Ras-MAPK in striatal neurons. Mol. Neurobiol. 29 (2004) 1-14
189. A or glycine receptors. J. Pharmacol. Exp. Ther. 290 (1999) 362-367
190. Watanabe T., Nakagawa T., Yamamoto R., Maeda A., Minami M., and Satoh M. Involvement of glutamate receptors within the central nucleus of the amygdala in naloxone-precipitated morphine withdrawal-induced conditioned place aversion in rats. Jpn. J. Pharmacol. 88 (2002) 399-406
191. Weiss F., and Baptista M. mGlu2/3 agonist (LY379268) selectively reverses conditioned reinstatement of cocaine seeking behavior. Behav. Pharmacol. 14 (2003) S27
192. Whistler J.L., and von Zastrow M. Dissociation of functional roles of dynamin in receptor-mediated endocytosis and mitogenic signal transduction. J. Biol. Chem. 274 (1999) 24575-24578
193. White F.J. Synaptic regulation of mesocorticolimbic dopamine neurons. Ann. Rev. Neurosci. 19 (1996) 405-436
194. Wise R.A. Neurobiology of addiction. Curr. Opin. Neurobiol. 6 (1996) 243-251
195. Wolf M.E. The role of excitatory amino acids in behavioral sensitization to psychomotor stimulants. Prog. Neurobiol. 54 (1998) 679-720
196. Wong C.S., Cherng C.H., Luk H.N., Ho S.T., and Tung C.S. Effects of NMDA receptor antagonists on inhibition of morphine tolerance in rats: binding at mu-opioid receptors. Eur. J. Pharmacol. 297 (1996) 27-33
197. A receptors-an in vivo electrochemical study. Brain Res. 798 (1998) 156-165
198. Xi Z.X., and Stein E.A. Baclofen inhibits heroin self-administration and mesolimbic dopamine release. J. Pharmacol. Exp. Ther. 290 (1999) 1369-1374
199. Xi Z.X., and Stein E.A. Blockade of ionotropic glutamatergic transmission in the ventral tegmental area reduces heroin reinforcement in rat. Psychopharmacology 164 (2002) 144-150
200. Xi Z.X., and Stein E.A. GABAergic mechanisms of opiate reinforcement. Alcohol Alcohol. 37 (2002) 485-494
201. Xiao B., Tu J.C., and Worley P.F. Homer: a link between neural activity and glutamate receptor function. Curr. Opin. Neurobiol. 10 (2000) 370-374
202. Xu L., Zhao Y., Zhan S.Q., Tang X.D., Guo Y., Wang H.S., and Yang C. Temporal and spatial expression of preprotachykinin A messenger RNA in the developing filial mice brain after maternal administration of monosodium glutamate at a late stage of pregnancy. Neuroscience 145 (2007) 974-980
203. Yamaguchi T., Sheen W., and Morales M. Glutamatergic neurons are present in the rat ventral tegmental area. Eur. J. Neurosci. 25 (2007) 106-118
204. Yamakura T., Sakimura K., and Shimoji K. Direct inhibition of the N-methyl-d-aspartate receptor channel by high concentrations of opioids. Anesthesiology 91 (1999) 1053-1063
205. Young A.B., and Fagg G.E. Excitatory amino acid receptors in the brain: membrane binding and receptor autoradiographic approaches. Trends Pharmacol. Sci. 11 (1990) 126-133
206. Youngren K.D., Daly D.A., and Moghaddam B. Distinct actions of endogenous excitatory amino acids on the outflow of dopamine in the nucleus accumbens. J. Pharmacol. Exp. Ther. 264 (1993) 289-293
207. Zarrindast M.R., and Mousa-Ahmadi E. Effects of GABAergic system on naloxone-induced jumping in morphine-dependent mice. Eur. J. Pharmacol. 381 (1999) 129-133
208. Zhang L., Lou D., Jiao H., Zhang D., Wang X., Xia Y., Zhang J., and Xu M. Cocaine-induced intracellular signaling and gene expression are oppositely regulated by the dopamine D1 and D3 receptors. J. Neurosci. 24 (2004) 3344-3354
209. Zhang Q., Zhao Y., Guo Y., Cao D.Y., Tian Y.L., Yao F.R., and Wang H.S. Electrophysiological evidence for the interaction of substance P and glutamate on Aδ and C afferent fibre activity in rat hairy skin. Clin. Exp. Pharmacol. Physiol. 33 (2006) 1128-1133
210. Zhou Q., Frandberg P.A., Kindlundh A.M., Greves P.L., and Nyberg F. Substance P(1-7) affects the expression of dopamine D2 receptor mRNA in male rat brain during morphine withdrawal. Peptides 24 (2003) 147-153
211. Zhou Q., and Nyberg F. Injection of substance P (SP) N-terminal fragment SP(1-7) into the ventral tegmental area modulates the levels of nucleus accumbens dopamine and dihydroxyphenylacetic acid in male rats during morphine withdrawal. Neurosci. Lett. 320 (2002) 117-120
212. Zhu H., and Barr G.A. The role of AMPA and metabotropic glutamate receptors on morphine withdrawal in infant rats. Int. J. Dev. Neurosci. 22 (2004) 379-395
213. Zhu H., Rockhold R.W., and Ho I.K. The role of glutamate in physical dependence on opioids. Jpn. J. Pharmacol. 76 (1998) 1-14